We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
AbbVie sent shockwaves through the drug industry Tuesday, announcing that it had reached a deal to acquire fellow drug giant Allergan for approximately $63 billion. Read More
Janssen’s Spravato (esketamine) spray—approved by the FDA in March for treatment-resistant depression —isn’t cost-effective at its listed price, a nonprofit drug price watchdog says. Read More
President Trump on Monday signed what he termed a “breakthrough” executive order requiring hospitals to inform patients of the prices they hash out with insurers. Read More